T3	Subject 0 46	A patient with chronic myelomonocytic leukemia
T5	Effect 70 88	pulmonary toxicity
T6	Treatment 95 124	using low dose oral etoposide
T7	Sub-Disorder 15 46	chronic myelomonocytic leukemia
T8	Route 110 114	oral
T9	Drug 115 124	etoposide
T4	Adverse_event 47 56	developed
E1	Adverse_event:T4 
T1	Dosage 101 109	low dose
